Hinge Health, Inc.·4

Feb 13, 4:34 PM ET

Perez Daniel Antonio 4

4 · Hinge Health, Inc. · Filed Feb 13, 2026

Research Summary

AI-generated summary of this filing

Updated

Hinge Health (HNGE) 10% Owner Daniel Perez Sells Shares

What Happened

  • Daniel Antonio Perez, a 10% owner of Hinge Health (HNGE), converted 166,665 derivative shares into common stock and sold 166,665 shares in an open-market transaction on February 12, 2026. The weighted-average sale price was $40.26, generating proceeds of approximately $6,710,516. The conversion was reported at $0.00 (no cash paid) and the resulting shares were disposed the same day.

Key Details

  • Transaction date: February 12, 2026
  • Sale: 166,665 shares sold; weighted-average price $40.26; total proceeds ≈ $6,710,516
  • Price range: shares sold between $40.00 and $40.88 (weighted average reported; seller offers to provide per-price detail on request) [F2]
  • Conversion: 166,665 derivative/Class B shares converted into Class A common stock (reported at $0.00) prior to/along with the sale [F3]
  • Plan/authorization: Sales were effected under a Rule 10b5-1 trading plan adopted Sept 11, 2025 [F1]
  • Shares owned after transaction: filing does not state total shares owned after the sale; filing notes exclusion of 4,721,252 performance stock units held by Perez [F4]
  • Filing timeliness: no late filing indicated in the report

Context

  • This was a planned sale by a 10% owner under a pre-established 10b5-1 plan, which is typically used to schedule routine dispositions and does not by itself indicate a change in the insider’s view of the company. The transaction involved conversion of convertible (Class B) shares into Class A shares and immediate sale of those shares. For retail investors, purchases typically carry more informational weight than planned sales; this filing documents a routine monetization of equity by a large shareholder.

Insider Transaction Report

Form 4
Period: 2026-02-12
Perez Daniel Antonio
DirectorCEO & Co-Founder10% Owner
Transactions
  • Conversion

    Class A Common Stock

    2026-02-12+166,665166,665 total
  • Sale

    Class A Common Stock

    [F1][F2]
    2026-02-12$40.26/sh166,665$6,710,5160 total
  • Conversion

    Class B Common Stock

    [F3][F4]
    2026-02-12166,6659,488,845 total
    Class A Common Stock (166,665 underlying)
Holdings
  • Class A Common Stock

    (indirect: By Spouse)
    35,470
  • Class B Common Stock

    [F3]
    (indirect: By Spouse)
    Class A Common Stock (515,705 underlying)
    515,705
Footnotes (4)
  • [F1]The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2025.
  • [F2]Represents the weighted average sale price. The lowest price at which shares were sold was $40.00 and the highest price at which shares were sold was $40.88. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
  • [F3]Each share of Class B Common Stock is convertible into one share of the lssuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.
  • [F4]Excludes 4,721,252 performance stock units held by the Reporting Person.
Signature
/s/ James Budge, Attorney-in-Fact|2026-02-13

Documents

1 file
  • 4
    form4-02132026_090212.xmlPrimary